Adagio Medical Holdings, Inc.
ADGM
$1.25
$0.086.84%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -74.77% | -19.30% | 116.54% | 100.67% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -74.77% | -19.30% | 116.54% | 100.67% |
| Cost of Revenue | -79.39% | 0.94% | 48.48% | 97.97% | 154.06% |
| Gross Profit | 74.82% | -26.86% | -67.63% | -94.07% | -169.98% |
| SG&A Expenses | -47.66% | -33.31% | 11.07% | 26.47% | 73.55% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -38.69% | -16.12% | 5.39% | 12.34% | 25.91% |
| Operating Income | 37.63% | 15.11% | -5.72% | -11.42% | -25.11% |
| Income Before Tax | 66.89% | -193.12% | -122.30% | -109.87% | -103.60% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 66.89% | -193.12% | -122.30% | -109.87% | -103.60% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 66.89% | -193.12% | -122.30% | -109.87% | -103.60% |
| EBIT | 37.63% | 15.11% | -5.72% | -11.42% | -25.11% |
| EBITDA | 37.95% | 15.86% | -4.22% | -9.70% | -22.48% |
| EPS Basic | 92.79% | 82.47% | 88.46% | 74.32% | 55.38% |
| Normalized Basic EPS | 91.54% | 93.38% | 95.91% | 81.15% | 61.94% |
| EPS Diluted | 92.30% | 82.10% | 88.21% | 74.29% | 55.38% |
| Normalized Diluted EPS | 91.52% | 93.37% | 96.04% | 81.27% | 62.05% |
| Average Basic Shares Outstanding | 150.45% | 407.22% | 1,713.25% | 1,247.80% | 777.59% |
| Average Diluted Shares Outstanding | 138.40% | 356.44% | 1,757.00% | 1,291.82% | 821.94% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |